Marrone, Lara
Drexler, Hannes C. A.
Wang, Jie
Tripathi, Priyanka
Distler, Tania
Heisterkamp, Patrick
Anderson, Eric Nathaniel
Kour, Sukhleen
Moraiti, Anastasia
Maharana, Shovamayee
Bhatnagar, Rajat
Belgard, T. Grant
Tripathy, Vadreenath
Kalmbach, Norman
Hosseinzadeh, Zohreh
Crippa, Valeria
Abo-Rady, Masin
Wegner, Florian
Poletti, Angelo
Troost, Dirk
Aronica, Eleonora
Busskamp, Volker
Weis, Joachim
Pandey, Udai Bhan
Hyman, Anthony A.
Alberti, Simon
Goswami, Anand
Sterneckert, Jared http://orcid.org/0000-0002-7688-3124
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG FZ 111, DFG EXC 168)
Alexander von Humboldt-Stiftung (3.5-INI/1155756 STP)
Bundesministerium für Bildung und Forschung (01ED1601A, 01ED1601B)
Max-Planck-Gesellschaft
National Institute of Neurological Disorders and Stroke (R21NS094921, R01NS081303, R21NS100055, R21NS098379)
H2020 European Research Council (725836)
Muscular Dystrophy Association
Robert Packard Center for ALS Research, Johns Hopkins University
Article History
Received: 12 December 2018
Revised: 26 March 2019
Accepted: 26 March 2019
First Online: 1 April 2019
Compliance with ethical standards
:
: RB is an employee of Verge Genomics; TGB is a former employee of Verge Genomics and is currently the founder of The Bioinformatics CRO. AAH is a founder of Rheostat therapeutics. AAH is a founder of Dewpoint Therapeutics and a member of the board. SA is a consultant for Dewpoint Therapeutics.